6.
Canessa P, Santini D, Zanelli M, CAPECCHI V
. Pulmonary tumourlets and microcarcinoids in bronchiectasis. Monaldi Arch Chest Dis. 1997; 52(2):138-9.
View
7.
Charokopos N, Tsiamita M, Karkoulias K, Koumoundourou D, Aletra C, Dougenis D
. Carcinoid tumour behind bronchiectasis. Monaldi Arch Chest Dis. 2006; 65(2):110-3.
DOI: 10.4081/monaldi.2006.574.
View
8.
Wang J, Ren S, Liu Y, Guo K, Chen X, Wang Z
. Carcinoid Tumorlets Co-Existing with Chronic Pulmonary Inflammatory Processes: Imaging Findings and Histological Appearances. Med Sci Monit. 2020; 26:e926014.
PMC: 7507795.
DOI: 10.12659/MSM.926014.
View
9.
Feng S, Yang S
. The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations. Diagn Interv Radiol. 2019; 25(4):270-279.
PMC: 6622436.
DOI: 10.5152/dir.2019.18458.
View
10.
Travis W, Linnoila R, Tsokos M, Hitchcock C, Cutler Jr G, Nieman L
. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991; 15(6):529-53.
DOI: 10.1097/00000478-199106000-00003.
View
11.
Beasley M, Thunnissen F, Brambilla E, Hasleton P, Steele R, Hammar S
. Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol. 2000; 31(10):1255-65.
DOI: 10.1053/hupa.2000.19294.
View
12.
Halabi S, Owzar K
. The importance of identifying and validating prognostic factors in oncology. Semin Oncol. 2010; 37(2):e9-18.
PMC: 2929829.
DOI: 10.1053/j.seminoncol.2010.04.001.
View
13.
Bulbul Y, Eris B, Orem A, Gulsoy A, Oztuna F, Ozlu T
. Pulmonary atelectasis and survival in advanced non-small cell lung carcinoma. Ups J Med Sci. 2010; 115(3):176-80.
PMC: 2939518.
DOI: 10.3109/03009731003695624.
View
14.
Dediu M, CriSan E, Radut M, Tarlea A, Median D, Alexandru A
. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study. Lung Cancer. 2008; 63(2):271-6.
DOI: 10.1016/j.lungcan.2008.05.007.
View
15.
Gu K, Lee H, Lee K, Choi J, Woo S, Sohn I
. Integrated evaluation of clinical, pathological and radiological prognostic factors in squamous cell carcinoma of the lung. PLoS One. 2019; 14(10):e0223298.
PMC: 6777828.
DOI: 10.1371/journal.pone.0223298.
View
16.
Bischoff P, Trinks A, Wiederspahn J, Obermayer B, Pett J, Jurmeister P
. The single-cell transcriptional landscape of lung carcinoid tumors. Int J Cancer. 2022; 150(12):2058-2071.
DOI: 10.1002/ijc.33995.
View
17.
Lee S, Yoo J, Ju S, Cho Y, Kim J, Kim S
. Quantitative severity of pulmonary emphysema as a prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. Thorac Cancer. 2018; 10(3):421-427.
PMC: 6397901.
DOI: 10.1111/1759-7714.12920.
View
18.
Yang Z, Wang Z, Duan Y, Xu S
. Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung. Thorac Cancer. 2016; 7(6):633-638.
PMC: 5093170.
DOI: 10.1111/1759-7714.12377.
View
19.
Fink G, Krelbaum T, Yellin A, Bendayan D, Saute M, Glazer M
. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest. 2001; 119(6):1647-51.
DOI: 10.1378/chest.119.6.1647.
View
20.
Papaxoinis G, Lamarca A, Quinn A, Mansoor W, Nonaka D
. Clinical and Pathologic Characteristics of Pulmonary Carcinoid Tumors in Central and Peripheral Locations. Endocr Pathol. 2018; 29(3):259-268.
PMC: 6097045.
DOI: 10.1007/s12022-018-9530-y.
View